1,507
Views
1
CrossRef citations to date
0
Altmetric
Articles

Prognosis of primary or metachronous prostate cancer in multiple primary genitourinary cancers; a single center experience with long-term results

ORCID Icon, , , &
Pages 37-41 | Received 01 Aug 2020, Accepted 26 Aug 2020, Published online: 02 Aug 2021

References

  • Mariotto AB, Rowland JH, Ries LA, et al. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev. 2007;16(3):566–571.
  • Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003;26(1):79–83.
  • Gursel B, Meydan D, Ozbek N, et al. Multiple primary malignant neoplasms from the black sea region of Turkey. J Int Med Res. 2011;39(2):667–674.
  • Moertel CG. Multiple primary malignant neoplasms: historical perspectives. Cancer. 1977;40(S4):1786–1792.
  • Arrizabalaga M, Navarro J, Mora M, et al. Transitional carcinomas of the urinary tract: synchronous and metachronous lesions. Actas Urol Esp. 1994;18(8):782–796.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34.
  • Feng Y, Zhong M, Zeng S, et al. Metachronous triple primary neoplasms with primary prostate cancer, lung cancer, and colon cancer: a case report. Medicine. 2018;97(26):e11332.
  • Mukendi AM, Van Den Berg E, Pather S, et al. Metachronous or synchronous male breast and prostate cancers a duality to lookout for. F1000Res. 2018;7:1825.
  • Gallyamov EA, Agapov MA, Kubyshkin VA, Biktimirov RG, et al. Multiple primary neoplasia of kidney, prostate and colon. Khir Z im NI Pirogova. 2018;4:98–100.
  • Mukaiyama Y, Suzuki M, Morikawa T, et al. Multiple primary malignant neoplasms of the glottis, renal pelvis, urinary bladder, oral floor, prostate, and esophagus in a Japanese male patient: a case report. World J Surg Oncol. 2014;12:294.
  • Ozsoy O, Fioretta G, Ares C, et al. Incidental detection of synchronous primary tumours during staging workup for prostate cancer. Swiss Med Wkly. 2010;140(15–16):233–236.
  • Kinoshita Y, Singh A, Rovito PM, Jr., et al. Double primary cancers of the prostate and bladder: a literature review. Clin Prostate Cancer. 2004;3(2):83–86.
  • Naik A, Bhandari V, Saadvik RY, et al. Incidence of second primary malignant neoplasm in Malwa region of central India. J Cancer Res Ther. 2018;14(5):999–1004.
  • Wang H, Hou J, Zhang G, et al. Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in patients with lung cancer. Cancer Gene Ther. 2019;26(11–12):419–426.
  • Romaszko-Wojtowicz A, Buciński A, Doboszyńska A. Impact of smoking on multiple primary cancers survival: a retrospective analysis. Clin Exp Med. 2018;18(3):391–397.
  • Lee J, Park S, Kim S, et al. Characteristics and survival of breast cancer patients with multiple synchronous or metachronous primary cancers. Yonsei Med J. 2015;56(5):1213–1220.
  • Friedenson B. BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. MedGenMed. 2005;7(2):60.